Susquehanna Portfolio Strategies’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Sell
106,499
-82,683
-44% -$1.95M 0.04% 424
2026
Q1
$4.3M Buy
189,182
+48,185
+34% +$1.14M 0.06% 329
2025
Q4
$3.76M Buy
140,997
+100,704
+250% +$2.98M 0.06% 357
2025
Q3
$1.22M Sell
40,293
-135,733
-77% -$4.12M 0.02% 632
2025
Q2
$5.52M Buy
+176,026
New +$5.82M 0.12% 209

Other funds holding ENOV

Susquehanna Portfolio Strategies's ENOV Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Enovis (ENOV) stake by 44% in Q2 2026, selling an estimated $1.95M and leaving 106,499 shares worth $2.2M. The position accounts for 0.04% of the portfolio, ranked #424.

Susquehanna Portfolio Strategies first reported a position in ENOV in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.52M in Q2 2025. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Susquehanna Portfolio Strategies held 106,499 shares of Enovis worth $2.2M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 82,683 Enovis shares in Q2 2026, an estimated $1.95M.
  • Enovis made up 0.04% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #424 holding.
  • Susquehanna Portfolio Strategies first reported a position in Enovis in Q2 2025 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's Enovis position peaked at $5.52M in Q2 2025.
  • 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.